In the Know: Healthcare News for December 16, 2024

December 16  

HistoSonics is Expanding to Treat Pancreatic Tumors

First-In-Human Study Demonstrates the Potential of the Reprieve System in Patients with Acute Decompensated Heart Failure

Brooklyn Park Developing Massive Vacant Site Near Planned Blue Line Stop with Biotech Hub, Housing

Pfizer’s IBRANCE® in Combination with Standard-of-Care Therapies Extends Median Progression-Free Survival by Over 15 Months in Phase 3 PATINA Study in Patients with HR+, HER2+ Metastatic Breast Cancer

Medical Alley Appoints Sanford President & CEO Bill Gassen to Board of Directors

Philips Expands Partnership with Sim&Cure to Enhance Neurovascular Therapy

Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering

SPR® Therapeutics Recognized as the Fastest Growing Private Company in Northeast Ohio as Part of the Crain’s Fast 50 List

Envoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing Loss

Baxter Announces Continued Growth of Pharmaceuticals Portfolio with Five Injectable Product Launches in the U.S.

Three MillerKnoll Certified Dealers Rebrand as One Integrated Workplace Solutions Company: Continua Interiors

Humanetics Secures Additional Funding to Advance Development of Its Drug to Prevent Radiation Injury

Lilly’s Omvoh® (mirikizumab) recommended by CHMP for approval in the European Union for adults with moderately to severely active Crohn’s disease

The Health Marketing Collective Wins Signal Award for Podcast Excellence

Boston Scientific has a new Peripheral Interventions leader in EMEA

Alfred Health becomes first in Southern Hemisphere to adopt GE HealthCare’s Command Center software proven to optimize operations

>
Success message!
Warning message!
Error message!